Literature DB >> 29058294

A novel gene mutation of Runx2 in cleidocranial dysplasia.

You-Jian Peng1, Qiao-Yun Chen1, Dong-Jie Fu1, Zhi-Ming Liu1, Tian-Tian Mao1, Jun Li1, Wen-Ting She2.   

Abstract

Haploinsufficiency of the runt-related transcription factor 2 (Runx2) gene is widely known to be responsible for cleidocranial dysplasia (CCD). To date, more than 190 mutations in Runx2 gene have been reported to be related to CCD. In this study, a novel mutation of Runx2 gene was observed in a female with CCD. Genomic DNA was extracted from peripheral venous blood of the proband and eleven members of her family. Genetic testing on these twelve people identified a novel missense mutation (c.895 T>C, Y299H) in exon 5 of the RUNX2 gene in the proband. This mutation results in an amino acid change at codon 895 (P.Tyr 299 His.) from a tryptophan codon (TAT) to a histidine codon (CAT). Our finding may further extend the known mutation spectrum of the RUNX2 gene, and facilitate prenatal genetic diagnosis of CCD in the future.

Entities:  

Keywords:  RUNX2; cleidocranial dysplasia; genetic testing; mutation

Mesh:

Substances:

Year:  2017        PMID: 29058294     DOI: 10.1007/s11596-017-1803-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  27 in total

1.  Cleidocranial dysplasia: oral features and genetic analysis of 11 patients.

Authors:  A Bufalino; L M R Paranaíba; A F Gouvêa; L A Gueiros; H Martelli-Júnior; J J Junior; M A Lopes; E Graner; O P De Almeida; P A Vargas; R D Coletta
Journal:  Oral Dis       Date:  2011-10-24       Impact factor: 3.511

2.  RUNX2 mutations in cleidocranial dysplasia patients.

Authors:  H-M Ryoo; H-Y Kang; S-K Lee; K-E Lee; J-W Kim
Journal:  Oral Dis       Date:  2009-09-08       Impact factor: 3.511

Review 3.  Cleidocranial dysplasia and RUNX2-clinical phenotype-genotype correlation.

Authors:  A Jaruga; E Hordyjewska; G Kandzierski; P Tylzanowski
Journal:  Clin Genet       Date:  2016-06-30       Impact factor: 4.438

4.  Cleidocranial dysplasia: Clinical, endocrinologic and molecular findings in 15 patients from 11 families.

Authors:  Firdevs Dinçsoy Bir; Nuriye Dinçkan; Yeliz Güven; Firdevs Baş; Umut Altunoğlu; Senem S Kuvvetli; Şükran Poyrazoğlu; Güven Toksoy; Hülya Kayserili; Z Oya Uyguner
Journal:  Eur J Med Genet       Date:  2016-12-24       Impact factor: 2.708

Review 5.  Covalent Modifications of RUNX Proteins: Structure Affects Function.

Authors:  Ezra Blumenthal; Sarah Greenblatt; Guang Huang; Koji Ando; Ye Xu; Stephen D Nimer
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

6.  Role of the RUNX2 p.R225Q mutation in cleidocranial dysplasia: a rare presentation and an analysis of the RUNX2 protein structure.

Authors:  L Z Wu; W Q Su; Y F Liu; X Ge; Y Zhang; X J Wang
Journal:  Genet Mol Res       Date:  2014-02-27

7.  Mutual effect between neuropeptides and inflammatory cytokines in neurogenic SMSCs of human temporomandibular joint.

Authors:  Zhi-Ming Liu; You-Jian Peng; Xing Long; Jian Li; Jin Ke; Wei Fang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

8.  Craniofacial and temporal bone CT findings in cleidocranial dysplasia.

Authors:  Guido E Gonzalez; Paul A Caruso; Juan E Small; Robert W Jyung; Maria J Troulis; Hugh D Curtin
Journal:  Pediatr Radiol       Date:  2008-04-30

9.  Cleidocranial dysplasia with autosomal dominant inheritance pattern.

Authors:  P Bhargava; S Khan; R Sharma; S Bhargava
Journal:  Ann Med Health Sci Res       Date:  2014-07

Review 10.  A limb-girdle myopathy phenotype of RUNX2 mutation in a patient with cleidocranial dysplasia: a case study and literature review.

Authors:  Sung-Ju Hsueh; Ni-Chung Lee; Shu-Hua Yang; Han-I Lin; Chin-Hsien Lin
Journal:  BMC Neurol       Date:  2017-01-06       Impact factor: 2.474

View more
  1 in total

1.  Identification of RUNX2 variants associated with cleidocranial dysplasia.

Authors:  Xueren Gao; Kunxia Li; Yanjie Fan; Yu Sun; Xiaomei Luo; Lili Wang; Huili Liu; Zhuwen Gong; Jianguo Wang; Yu Wang; Xuefan Gu; Yongguo Yu
Journal:  Hereditas       Date:  2019-09-16       Impact factor: 3.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.